[1]
Guven, S. et al. 2023. Amniotic Fluid Ischemia Modified Albumin as a Novel Prenatal Diagnostic Marker for Down Syndrome: A Prospective Case-Control Study. Clinical Journal of Obstetrics and Gynecology. 6, 2 (Jun. 2023), 082–087. DOI:https://doi.org/10.29328/journal.cjog.1001133.